Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03365778 · ClinicalTrials.gov registry record · NA
Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT03365778 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 86 participants.
The verdict
NCT03365778, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
The purpose of this study is to develop an educational program that will help improve the patients' understanding of what laser treatment is, how it might be beneficial to them, and why it should be the first eye pressure lowering glaucoma treatment to consider before the use of glaucoma eye drops.
Interventions
- OTHER Usual Care
- OTHER Patient Educational Intervention
- OTHER Ophthalmologist Educational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2017-10-23 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03365778
The ClinicalTrials.gov registry entry for NCT03365778 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT03365778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03365778 about?
NCT03365778 is a clinical study titled "Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment". The purpose of this study is to develop an educational program that will help improve the patients' understanding of what laser treatment is, how it might be beneficial to them, and why it should be the first eye pressure lowering glaucoma treatment to consider before the use of glaucoma eye drops.
What is the current status of trial NCT03365778?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2017-10-23. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03365778?
The interventions under investigation include: Usual Care (OTHER), Patient Educational Intervention (OTHER), Ophthalmologist Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT03365778?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.